Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Baker Hughes Q1 Profit Down - Quick Facts

RELATED NEWS
Trade BHI now with 

Oil services provider Baker Hughes Inc. (BHI: Quote) reported a slight decline in its first-quarter 2012 net income attributable to the company to $379 million or $0.86 per share from $381 million or $0.87 per share last year. On average, 29 analysts polled by Thomson Reuters expected earnings per share of $0.80 for the quarter. Analysts' estimates typically exclude one-time items.

Revenue for the 2012 first quarter was $5.36 billion, up 18% from $4.53 billion a year ago, while 20 analysts estimated revenues of $5.22 billion for the quarter.

The company noted, "We expect to realize significant benefits from these improvements in the second half of 2012; however, it is clear that the overall market is experiencing pricing pressure that is likely to extend throughout 2012."

Click here to receive FREE breaking news email alerts for Baker Hughes and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After ending the previous session modestly lower, stocks have shown a strong move back to the upside during trading on Tuesday. With the upward move on the day, the S&P 500 has reached a new record intraday high. A majority of Americans believe Israel is justified in taking military action against Gaza, according to the results of a new CNN/ORC International survey, although opinions about the amount of military force the Israelis have used are more divided. After reporting a sharp increase in existing home sales in the previous month, the National Association of Realtors released a report on Tuesday showing that existing home sales once again rose by more than expected in the month of June.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.